XML 50 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Aug. 05, 2013
Jan. 31, 2024
Dec. 31, 2023
Dec. 18, 2023
Dec. 31, 2022
Dec. 31, 2021
Nov. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]              
Net loss     $ (18,754)   $ (33,694) $ (34,203)  
Accumulated deficit     (474,527)   (455,773)    
Net cash used in operating activities     (35,886)   $ (34,113) $ (22,691)  
Non-refundable upfront payment       $ 60,000      
Milestone payment       30,000      
Potential milestone compensation company is now eligible for       $ 758,000      
Preclinical milestone compensation $ 23,200            
Amount of investment in Compugen     12,000       $ 20,000
Upfront payment received 10,000   10,000        
Accrued milestone payment     25,500        
Potential milestone compensation $ 250,000   $ 200,000        
Percentage of expected from upfront payment amount paid   15.00%